{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:03:39Z","timestamp":1793325819503,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s40262-019-00854-1","type":"journal-article","created":{"date-parts":[[2019,12,15]],"date-time":"2019-12-15T21:02:28Z","timestamp":1576443748000},"page":"771-780","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Unbound Plasma, Total Plasma, and Whole-Blood Tacrolimus Pharmacokinetics Early After Thoracic Organ Transplantation"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3872-5771","authenticated-orcid":false,"given":"Maaike A.","family":"Sikma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik M.","family":"Van Maarseveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7843-6208","authenticated-orcid":false,"given":"Claudine C.","family":"Hunault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier M.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed A.","family":"Van de Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4635-5216","authenticated-orcid":false,"given":"Johannes H.","family":"Kirkels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3276-6428","authenticated-orcid":false,"given":"Marianne C.","family":"Verhaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3670-8097","authenticated-orcid":false,"given":"Jan C.","family":"Grutters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3007-8445","authenticated-orcid":false,"given":"Jozef","family":"Kesecioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0191-7270","authenticated-orcid":false,"given":"Dylan W.","family":"De Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alwin D. R.","family":"Huitema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,16]]},"reference":[{"issue":"31","key":"854_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/ftd.0b013e318198d092","volume":"2009","author":"P Wallemacq","year":"2009","unstructured":"Wallemacq P, Armstrong VW, Brunet M, Haufroid V, Holt DW, Johnston A, et al. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit. 2009;2009(31):139\u201352. https:\/\/doi.org\/10.1097\/ftd.0b013e318198d092.","journal-title":"Ther Drug Monit."},{"key":"854_CR2","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1097\/tp.0000000000002052","volume":"102","author":"M Rayar","year":"2018","unstructured":"Rayar M, Tron C, J\u00e9z\u00e9quel C, Beaurepaire J-M, Petitcollin A, Houssel-Debry P, et al. High intrapatient variability of tacrolimus exposure in the early period after liver transplantation is associated with poorer outcomes. Transplantation. 2018;102:e108\u201314. https:\/\/doi.org\/10.1097\/tp.0000000000002052.","journal-title":"Transplantation."},{"key":"854_CR3","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1111\/ajt.15016","volume":"18","author":"I Gueta","year":"2018","unstructured":"Gueta I, Markovits N, Yarden-Bilavsky H, Raichlin E, Freimark D, Lavee J, et al. High tacrolimus trough level variability is associated with rejections after heart transplant. Am J Transplant. 2018;18:2571\u20138. https:\/\/doi.org\/10.1111\/ajt.15016.","journal-title":"Am J Transplant."},{"key":"854_CR4","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/ajt.12191","volume":"13","author":"R Bouamar","year":"2013","unstructured":"Bouamar R, Shuker N, Hesselink DA, Weimar W, Ekberg H, Kaplan B, et al. Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(\u2020). Am J Transplant. 2013;13:1253\u201361. https:\/\/doi.org\/10.1111\/ajt.12191.","journal-title":"Am J Transplant."},{"key":"854_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s13318-017-0453-7","volume":"43","author":"MA Sikma","year":"2018","unstructured":"Sikma MA, Hunault CC, Kirkels JH, Verhaar MC, Kesecioglu J, de Lange DW. Association of whole blood tacrolimus concentrations with kidney injury in heart transplantation patients. Eur J Drug Metab Pharmacokinet. 2018;43:311\u201320. https:\/\/doi.org\/10.1007\/s13318-017-0453-7.","journal-title":"Eur J Drug Metab Pharmacokinet."},{"key":"854_CR6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00228-017-2204-8","volume":"73","author":"MA Sikma","year":"2017","unstructured":"Sikma MA, Hunault CC, van de Graaf EA, Verhaar MC, Kesecioglu J, de Lange DW, et al. High tacrolimus blood concentrations early after lung transplantation and the risk of kidney injury. Eur J Clin Pharmacol. 2017;73:573\u201380. https:\/\/doi.org\/10.1007\/s00228-017-2204-8.","journal-title":"Eur J Clin Pharmacol."},{"key":"854_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s1056-8719(02)00158-2","volume":"46","author":"H Zahir","year":"2001","unstructured":"Zahir H, Nand RA, Brown KF, Tattam BN. Validation of methods to study the distribution and protein binding of tacrolimus in human blood. J Pharmacol Toxicol Methods. 2001;46:27\u201335. https:\/\/doi.org\/10.1016\/s1056-8719(02)00158-2.","journal-title":"J Pharmacol Toxicol Methods."},{"key":"854_CR8","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1046\/j.1365-2125.2003.02008.x","volume":"57","author":"H Zahir","year":"2004","unstructured":"Zahir H, McCaughan G, Gleeson M, Nand RA, McLachlan AJ. Factors affecting variability in distribution of tacrolimus in liver transplant recipients. Br J Clin Pharmacol. 2004;57:298\u2013309. https:\/\/doi.org\/10.1046\/j.1365-2125.2003.02008.x.","journal-title":"Br J Clin Pharmacol."},{"key":"854_CR9","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/ftd.0b013e3182708edf","volume":"34","author":"S Zheng","year":"2012","unstructured":"Zheng S, Easterling TR, Umans JG, Miodovnik M, Calamia JC, Thummel KE, Shen DD, Davis CL, Hebert MF. Pharmacokinetics of tacrolimus during pregnancy. Ther Drug Monit. 2012;34:660\u201370. https:\/\/doi.org\/10.1097\/ftd.0b013e3182708edf","journal-title":"Ther Drug Monit."},{"key":"854_CR10","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s40262-016-0396-1","volume":"55","author":"E Brooks","year":"2016","unstructured":"Brooks E, Tett SE, Isbel NM, Staatz CE. Population pharmacokinetic modelling and Bayesian estimation of tacrolimus exposure: is this clinically useful for dosage prediction yet? Clin Pharmacokinet. 2016;55:1295\u2013335. https:\/\/doi.org\/10.1007\/s40262-016-0396-1.","journal-title":"Clin Pharmacokinet."},{"key":"854_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00467-018-4117-x","volume":"34","author":"AM Schijvens","year":"2019","unstructured":"Schijvens AM, van Hesteren FHS, Cornelissen EAM, Bootsma-Robroeks CMHHT, Br\u00fcggemann RJM, Burger DM, et al. The potential impact of hematocrit correction on evaluation of tacrolimus target exposure in pediatric kidney transplant patients. Pediatr Nephrol. 2019;34:507\u201315. https:\/\/doi.org\/10.1007\/s00467-018-4117-x.","journal-title":"Pediatr Nephrol"},{"key":"854_CR12","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/00007691-200410000-00008","volume":"26","author":"H Zahir","year":"2004","unstructured":"Zahir H, McCaughan G, Gleeson M, Nand RA, McLachlan AJ. Changes in tacrolimus distribution in blood and plasma protein binding following liver transplantation. Ther Drug Monit. 2004;26:506\u201315. https:\/\/doi.org\/10.1097\/00007691-200410000-00008.","journal-title":"Ther Drug Monit."},{"key":"854_CR13","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1097\/TP.0b013e318278d367","volume":"95","author":"MF Hebert","year":"2013","unstructured":"Hebert MF, Zheng S, Hays K, Shen DD, Davis CL, Umans JG, et al. Interpreting tacrolimus concentrations during pregnancy and postpartum. Transplantation. 2013;95:908\u201315. https:\/\/doi.org\/10.1097\/TP.0b013e318278d367.","journal-title":"Transplantation."},{"key":"854_CR14","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1111\/ajt.13309","volume":"15","author":"MA Sikma","year":"2015","unstructured":"Sikma MA, van Maarseveen EM, van de Graaf EA, Kirkels JH, Verhaar MC, Donker DW, et al. Pharmacokinetics and toxicity of tacrolimus early after heart and lung transplantation. Am J Transplant. 2015;15:2301\u201313. https:\/\/doi.org\/10.1111\/ajt.13309.","journal-title":"Am J Transplant."},{"key":"854_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.chroma.2018.03.010","volume":"1547","author":"H Bittersohl","year":"2018","unstructured":"Bittersohl H, Schniedewind B, Christians U, Luppa PB. A simple and highly sensitive on-line column extraction liquid chromatography\u2013tandem mass spectrometry method for the determination of protein-unbound tacrolimus in human plasma samples. J Chromatogr A. 2018;1547:45\u201352. https:\/\/doi.org\/10.1016\/j.chroma.2018.03.010.","journal-title":"J Chromatogr A."},{"key":"854_CR16","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/FTD.0000000000000351","volume":"38","author":"NA Stienstra","year":"2016","unstructured":"Stienstra NA, Sikma MA, van Dapperen AL, de Lange DW, Van Maarseveen EM. Development of a simple and rapid method to measure the free fraction of tacrolimus in plasma using ultrafiltration and LC\u2013MS\/MS. Ther Drug Monit. 2016;38:722\u20137. https:\/\/doi.org\/10.1097\/FTD.0000000000000351.","journal-title":"Ther Drug Monit."},{"key":"854_CR17","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.clinbiochem.2013.08.013","volume":"46","author":"M Marinova","year":"2013","unstructured":"Marinova M, Artusi C, Brugnolo L, Antonelli G, Zaninotto M, Plebani M. Immunosuppressant therapeutic drug monitoring by LC\u2013MS\/MS: workflow optimization through automated processing of whole blood samples. Clin Biochem. 2013;46:1723\u20137. https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.08.013.","journal-title":"Clin Biochem."},{"key":"854_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10928-016-9487-8","volume":"43","author":"A-G Dosne","year":"2016","unstructured":"Dosne A-G, Bergstrand M, Harling K, Karlsson MO. Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resampling. J Pharmacokinet Pharmacodyn. 2016;43:583\u201396. https:\/\/doi.org\/10.1007\/s10928-016-9487-8.","journal-title":"J Pharmacokinet Pharmacodyn."},{"key":"854_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.2042-7158.1994.tb03752.x","volume":"46","author":"K Nagase","year":"1994","unstructured":"Nagase K, Iwasaki K, Nozaki K, Noda K. Distribution and protein binding of FK506, a potent immunosuppressive macrolide lactone, in human blood and its uptake by erythrocytes. J Pharm Pharmacol. 1994;46:113\u20137. https:\/\/doi.org\/10.1111\/j.2042-7158.1994.tb03752.x.","journal-title":"J Pharm Pharmacol."},{"key":"854_CR20","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2165\/11318080-000000000-00000","volume":"48","author":"K Benkali","year":"2009","unstructured":"Benkali K, Pr\u00e9maud A, Picard N, R\u00e9rolle J-P, Toupance O, Hoizey G, et al. Tacrolimus population pharmacokinetic\u2013pharmacogenetic analysis and Bayesian estimation in renal transplant recipients. Clin Pharmacokinet. 2009;48:805\u201316. https:\/\/doi.org\/10.2165\/11318080-000000000-00000.","journal-title":"Clin Pharmacokinet"},{"key":"854_CR21","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/bcp.12703","volume":"80","author":"H De Jonge","year":"2015","unstructured":"De Jonge H, Vanhove T, de Loor H, Verbeke K, Kuypers DRJ. Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit. Br J Clin Pharmacol. 2015;80:548\u201359. https:\/\/doi.org\/10.1111\/bcp.12703.","journal-title":"Br J Clin Pharmacol."},{"key":"854_CR22","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s40262-017-0567-8","volume":"57","author":"LM Andrews","year":"2018","unstructured":"Andrews LM, Hesselink DA, Van Gelder T, Koch BCP, Cornelissen EAM, Br\u00fcggemann RJM, et al. A population pharmacokinetic model to predict the individual starting dose of tacrolimus following pediatric renal transplantation. Clin Pharmacokinet. 2018;57:475\u201389. https:\/\/doi.org\/10.1007\/s40262-017-0567-8.","journal-title":"Clin Pharmacokinet."},{"key":"854_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/bcp.12361","volume":"78","author":"E St\u00f8rset","year":"2014","unstructured":"St\u00f8rset E, Holford N, Hennig S, Bergmann TK, Bergan S, Bremer S, et al. Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling. Br J Clin Pharmacol. 2014;78:509\u201323. https:\/\/doi.org\/10.1111\/bcp.12361.","journal-title":"Br J Clin Pharmacol."},{"key":"854_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00228-013-1584-7","volume":"70","author":"E St\u00f8rset","year":"2014","unstructured":"St\u00f8rset E, Holford N, Midtvedt K, Bremer S, Bergan S, \u00c5sberg A. Importance of hematocrit for a tacrolimus target concentration strategy. Eur J Clin Pharmacol. 2014;70:65\u201377. https:\/\/doi.org\/10.1007\/s00228-013-1584-7.","journal-title":"Eur J Clin Pharmacol."},{"key":"854_CR25","first-page":"610","volume":"25","author":"F-S Chow","year":"1997","unstructured":"Chow F-S, Piekoszewski W, Jusko WJ. Effect of hematocrit and albumin concentration on hepatic clearance of tacrolimus (FK506) during rabbit liver perfusion. Drug Metab Dispos. 1997;25:610\u20136.","journal-title":"Drug Metab Dispos."},{"key":"854_CR26","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/iub.478","volume":"63","author":"S Biagiotti","year":"2011","unstructured":"Biagiotti S, Paoletti MF, Fraternale A, Rossi L, Magnani M. Drug delivery by red blood cells. IUBMB Life. 2011;63:621\u201331. https:\/\/doi.org\/10.1002\/iub.478.","journal-title":"IUBMB Life."},{"key":"854_CR27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jconrel.2011.05.024","volume":"154","author":"S Biagiotti","year":"2011","unstructured":"Biagiotti S, Rossi L, Bianchi M, Giacomini E, Pierig\u00e8 F, Serafini G, et al. Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs. J Control Release. 2011;154:306\u201313. https:\/\/doi.org\/10.1016\/j.jconrel.2011.05.024.","journal-title":"J Control Release."},{"key":"854_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1083\/jcb.141.1.143","volume":"141","author":"LD Walensky","year":"1998","unstructured":"Walensky LD, Gascard P, Fields ME, Blackshaw S, Conboy JG, Mohandas N, et al. The 13-kD FK506 binding protein, FKBP13, interacts with a novel homologue of the erythrocyte membrane cytoskeletal protein 4.1. J Cell Biol. 1998;141:143\u201353. https:\/\/doi.org\/10.1083\/jcb.141.1.143.","journal-title":"J Cell Biol"},{"key":"854_CR29","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1242\/jcs.00948","volume":"117","author":"K Van Acker","year":"2004","unstructured":"Van Acker K, Bultynck G, Rossi D, Sorrentino V, Boens N, Missiaen L, et al. The 12\u00a0kDa FK506-binding protein, FKBP12, modulates the Ca(2\u2009+)-flux properties of the type-3 ryanodine receptor. J Cell Sci. 2004;117:1129\u201337. https:\/\/doi.org\/10.1242\/jcs.00948.","journal-title":"J Cell Sci."},{"key":"854_CR30","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3978\/j.issn.2072-1439.2014.04.23","volume":"6","author":"JL Scheffert","year":"2014","unstructured":"Scheffert JL, Raza K. Immunosuppression in lung transplantation. J Thorac Dis. 2014;6:1039\u201353. https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2014.04.23.","journal-title":"J Thorac Dis."},{"key":"854_CR31","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.5980\/jpnjurol1989.84.1088","volume":"23","author":"M Machida","year":"1991","unstructured":"Machida M, Takahara S, Ishibashi M, Hayashi M. Effect of temperature on hematocrit on plasma concentration of FK506. Transplant Proc. 1991;23:2753\u20134. https:\/\/doi.org\/10.5980\/jpnjurol1989.84.1088.","journal-title":"Transplant Proc."},{"key":"854_CR32","first-page":"2745","volume":"23","author":"AJ Beysens","year":"1991","unstructured":"Beysens AJ, Wijnen RM, Beuman GH, van der Heyden J, Kootstra G, van As H. FK 506: monitoring in plasma or in whole blood? Transplant Proc. 1991;23:2745\u20137.","journal-title":"Transplant Proc"},{"key":"854_CR33","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1208\/s12248-014-9577-8","volume":"16","author":"C G\u00e9rard","year":"2014","unstructured":"G\u00e9rard C, Stocco J, Hulin A, Blanchet B, Verstuyft C, Durand F, et al. Determination of the most influential sources of variability in tacrolimus trough blood concentrations in adult liver transplant recipients: a bottom-up approach. AAPS J. 2014;16:379\u201391. https:\/\/doi.org\/10.1208\/s12248-014-9577-8.","journal-title":"AAPS J."},{"key":"854_CR34","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/jps.2600820325","volume":"82","author":"W Piekoszewski","year":"1993","unstructured":"Piekoszewski W, Jusko WJ. Plasma protein binding of tacrolimus in humans. J Pharm Sci. 1993;82:340\u20131. https:\/\/doi.org\/10.1002\/jps.2600820325.","journal-title":"J Pharm Sci."}],"updated-by":[{"DOI":"10.1007\/s40262-022-01115-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000}}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-019-00854-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-019-00854-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-019-00854-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T12:23:07Z","timestamp":1646137387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-019-00854-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,16]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["854"],"URL":"https:\/\/doi.org\/10.1007\/s40262-019-00854-1","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,16]]},"assertion":[{"value":"16 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40262-022-01115-4","URL":"https:\/\/doi.org\/10.1007\/s40262-022-01115-4","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No sources of funding were received for the conduct of this study of the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Jozef Kesecioglu reports personal fees from an honorarium received from Xenios AG, outside the submitted work. Maaike A. Sikma, Erik M. Van Maarseveen, Claudine C. Hunault, Javier M. Moreno, Ed A. Van de Graaf, Johannes H. Kirkels, Marianne C. Verhaar, Jan C. Grutters, Dylan W. De Lange, and Alwin D.R. Huitema have no conflicts of interest that are directly relevant to the content of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}